Literature DB >> 33656730

A Survey of Psychological Distress Among the Community in the COVID-19 Epidemic: A Cross-Sectional Study.

Malihe Sadat Moayed1, Amir Vahedian-Azimi2, Golshan Mirmomeni3, Farshid Rahimi-Bashar4, Keivan Goharimoghadam5, Mohamad Amin Pourhoseingholi6, Mohsen Abbasi-Farajzadeh7, Mansour Babaei8, Thozhukat Sathyapalan9, Paul C Guest10, Amirhossein Sahebkar11,12,13,14.   

Abstract

Aim The ongoing COVID-19 outbreak has not only had an impact on physical health but also on psychological health. The aim of this study was to measure the prevalence and severity of psychological distress in the community due to the COVID-19 pandemic. Methods This cross-sectional survey was conducted in February and March 2020 in Tehran, Iran. We analyzed demographic characteristics and assessed depression, anxiety, and stress levels in 241 people using convenience sampling and the DASS-21 questionnaire. All statistical analyses were performed using R. Results The study population included 241 community-dwelling participants, of whom 145 were women and 96 were males. The mean age was 49.16 ± 8.01 years. Approximately two-thirds of participants (n = 158) reported no history of comorbid illness. The mean scores of depression and stress were at a "severe" level, while anxiety levels were at an "extremely severe" level. The prevalence of severe and extremely severe depression readings was 51.45 and 38.17%, respectively. In the anxiety subscale, the prevalence of severe and extremely severe depression was 95.90 and 4.1%, and in the stress subscale the prevalence was 48.97 and 4.98%, respectively. Conclusion In this study, people reported experiencing severe and extremely severe psychological distress. Therefore, there is an urgent need to implement mental health intervention policies to cope with this ongoing challenge. We suggest that the incorporation of molecular biomarker tests into the algorithm could aid in assessment of patients and guide the most appropriate therapeutic response.

Entities:  

Keywords:  Anxiety; COVID-19; Coronavirus; Depression; Iran; Psychological distress; Stress

Year:  2021        PMID: 33656730     DOI: 10.1007/978-3-030-59261-5_22

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  4 in total

Review 1.  BDNF as a biomarker in diagnosis and evaluation of treatment for schizophrenia and depression.

Authors:  Shiyong Peng; Wenqiang Li; Luxian Lv; Zhongjiang Zhang; Xiping Zhan
Journal:  Discov Med       Date:  2018-10       Impact factor: 2.970

2.  The psychological effects of quarantining a city.

Authors:  G James Rubin; Simon Wessely
Journal:  BMJ       Date:  2020-01-28

3.  Mental health status of people isolated due to Middle East Respiratory Syndrome.

Authors:  Hyunsuk Jeong; Hyeon Woo Yim; Yeong-Jun Song; Moran Ki; Jung-Ah Min; Juhee Cho; Jeong-Ho Chae
Journal:  Epidemiol Health       Date:  2016-11-05

Review 4.  Poststroke Depression Biomarkers: A Narrative Review.

Authors:  Oleg A Levada; Alexandra S Troyan
Journal:  Front Neurol       Date:  2018-07-16       Impact factor: 4.003

  4 in total
  1 in total

Review 1.  Prevalence of anxiety during the COVID-19 pandemic: A systematic review and meta-analysis of over 2 million people.

Authors:  Felipe Mendes Delpino; Carine Nascimento da Silva; Jeferson Santos Jerônimo; Eliete Stark Mulling; Larissa Leal da Cunha; Marina Krause Weymar; Ricardo Alt; Eduardo L Caputo; Natan Feter
Journal:  J Affect Disord       Date:  2022-09-10       Impact factor: 6.533

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.